| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 95480-67-4 | Atrial natriureticpeptide-24 (rat reduced) (9CI); Atriopeptin-21(rat reduced), 21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-; 303: PN:WO0069900 SEQID: 485 unclaimed sequence; 402: PN: US20090175821 SEQID: 485claimed protein; L-Tyrosine,L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl- |  | C107H167N35O34S2 | 詳情 | 供應(yīng)商 | |
| 223716-53-8 | Cardioactive peptide-23(Spodoptera eridania reduced) (9CI); 22: PN:WO2004087766 TABLE: 1 unclaimed sequence; 6: PN: JP2002068916 PAGE: 5 unclaimedsequence; L-Phenylalanine, L-a-glutamyl-L-asparaginyl-L-phenylalanyl-L-alanyl-L-valylglycyl-L-cysteinyl-L-threonyl-L-prolylglycyl-L-tyrosyl-L-glutaminyl-L-arginyl-L-threonyl-L-alanyl-L-a-aspartylglycyl-L-arginyl-L-cysteinyl-L-lysyl-L-prolyl-L-threonyl- |  | C108H164N32O34S2 | 詳情 | 供應(yīng)商 | |
| 87578-76-5 | Katacalcin (human),N-L-tyrosyl- (9CI); TYR-KATACALCIN); katacalcin [Tyr] |  | C106H163N35O38S2 | 詳情 | 供應(yīng)商 | |
| 162208-27-7 | AE活性硫酯 | 4-THIAZOLEACETIC ACID, 2-AMINO-ALPHA-(METHOXYIMINO)-, (AZ)-, ANHYDRIDE WITH O,O-DIETHYL HYDROGEN PHO; O,O-DIETHYLTHIOPHOSPHORYL (Z)-2-(2-AMINOTHIAZOL-4-YL)-2-METHOXYIMINOACETATE; 4-THIAZOLEACETIC ACID, 2-AMINO-ALPHA-(METHOXYIMINO)-, (AZ)-, ANHYDRIDE WITH O,O-DIETHYL HYDROGEN PHOSPHOROTHIOATE; DAMA; DIETHYL THIOPHOSPHORYL-(Z)-(2-AMINOTHIAZOL-4-YL)-(METHOXYIMINO)ACETATE; DAMA ,DIETHYL THIOPHOSPHORIL-(Z)-(2-AMINOTHIAZOL-4-YL)-( METHOXYIMINO)ACETATE; (Z)-DIETHYLTHIOPHOSPHORYL (2-AMINOTHIAZOL-4-YL)-ALPHA-(METHOXYIMINO)-ACETATE; DIETHYL THIOPOSPHORIL-(Z)-(2-AMINOTHIAZOL-4-YL)-(METHOXYIMINO)ACETATE; O-[2-(2-AMINO-1,3-THIAZOL-4-YL)-2-((Z)-METHOXYIMINO)ACETYL] O,O-DIETHYL PHOSPHOROTHIOATE |  | C10H16N3O3PS2*2 | 詳情 | 供應(yīng)商 |
| 90817-13-3 | ATRIOPEPTIN III (RAT); SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-AS | ATRIOPEPTIN III (RAT); ALPHA-ANF 5-28, RAT; ANP (5-28), RAT; ATRIAL NATRIURETIC PEPTIDE (5-28) RAT; ATRIOPEPTIN III (RAT); ATRIOPEPTIN III (RAT, RABBIT, MOUSE); ATRIOPEPTIN III; H-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR-OH; H-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR-OH (DISULFIDE BRIDGE: 3-19) |  | C107H165N35O34S2 | 詳情 | 供應(yīng)商 |
| 117856-13-0 | (TYR0)-ATRIOPEPTIN II (RAT); TYR-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU- | (TYR0)-ATRIOPEPTIN II (RAT); [TYR0]-ATRIAL NATRIURETIC PEPTIDE (5-27) RAT; (TYR0)-ATRIOPEPTIN II (RAT); [TYR0]-ATRIOPEPTIN II (RAT, RABBIT, MOUSE); [TYR126] ANP (126-149), RAT; TYR-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG; YSSCFGGRIDRIGAQSGLGCNSFR (DISULFIDE BRIDGE: 4-20); H-TYR-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-OH; H-TYR-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-OH (DISULFIDE BRIDGE: 4-20) |  | C107H165N35O34S2 | 詳情 | 供應(yīng)商 |
| 91421-87-3 | ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG(DISU | ATRIAL NATRIURETIC PEPTIDE (126-149) (RAT); ANP (126-149) (RAT); ANP (4-27), RAT; H-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-OH; AURICULIN A, RAT; ATRIAL NATRIURETIC PEPTIDE (126-149) (RAT); ATRIAL NATRIURETIC PEPTIDE (4-27), RAT; atrialnatriureticfactor(8-33; atrial natriuretic peptide*fragment 4-27 rat |  | C104H168N38O33S2 | 詳情 | 供應(yīng)商 |